Tibet Cheezheng Tibetan Medicine Co Ltd (002287) - Total Assets

Latest as of September 2025: CN¥6.64 Billion CNY ≈ $971.40 Million USD

Based on the latest financial reports, Tibet Cheezheng Tibetan Medicine Co Ltd (002287) holds total assets worth CN¥6.64 Billion CNY (≈ $971.40 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See what is Tibet Cheezheng Tibetan Medicine Co Ltd's book value for net asset value and shareholders' equity analysis.

Tibet Cheezheng Tibetan Medicine Co Ltd - Total Assets Trend (2006–2024)

This chart illustrates how Tibet Cheezheng Tibetan Medicine Co Ltd's total assets have evolved over time, based on quarterly financial data.

Tibet Cheezheng Tibetan Medicine Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2024)

Tibet Cheezheng Tibetan Medicine Co Ltd's total assets of CN¥6.64 Billion consist of 61.2% current assets and 38.8% non-current assets.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	2.8%
Accounts Receivable	CN¥949.09 Million	14.0%
Inventory	CN¥185.33 Million	2.7%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥325.50 Million	4.8%
Goodwill	CN¥0.00	0.0%

Asset Composition Trend (2006–2024)

This chart illustrates how Tibet Cheezheng Tibetan Medicine Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 002287 company net worth.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Tibet Cheezheng Tibetan Medicine Co Ltd's current assets represent 61.2% of total assets in 2024, a decrease from 82.5% in 2006.
Cash Position: Cash and equivalents constituted 2.8% of total assets in 2024, down from 52.0% in 2006.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, an increase from 1.0% in 2006.
Asset Diversification: The largest asset category is accounts receivable at 14.0% of total assets.

Tibet Cheezheng Tibetan Medicine Co Ltd Competitors by Total Assets

Key competitors of Tibet Cheezheng Tibetan Medicine Co Ltd based on total assets are shown below.

Company	Country	Total Assets
Fortress Biotech Inc NASDAQ:FBIO	USA	$185.55 Million
Summit Therapeutics PLC NASDAQ:SMMT	USA	$261.73 Million
Tubize-Fin BR:TUB	Belgium	€1.93 Billion
Apellis Pharmaceuticals Inc NASDAQ:APLS	USA	$1.08 Billion
Beijing Tiantan Biological Products Corp Ltd SHG:600161	China	CN¥16.55 Billion
BrightGene Bio Medical Technology C SHG:688166	China	CN¥5.38 Billion
BioArctic AB (publ) ST:BIOA-B	Sweden	Skr2.60 Billion
Chengzhi Shareholding Co Ltd SHE:000990	China	CN¥27.52 Billion

Tibet Cheezheng Tibetan Medicine Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	2.63	3.16	3.90
Quick Ratio	2.45	3.02	3.77
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥2.52 Billion	CN¥2.94 Billion	CN¥2.21 Billion

Tibet Cheezheng Tibetan Medicine Co Ltd - Advanced Valuation Insights

This section examines the relationship between Tibet Cheezheng Tibetan Medicine Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.89
Latest Market Cap to Assets Ratio	0.28
Asset Growth Rate (YoY)	7.8%
Total Assets	CN¥6.79 Billion
Market Capitalization	$1.90 Billion USD

Valuation Analysis

Below Book Valuation: The market values Tibet Cheezheng Tibetan Medicine Co Ltd's assets below their book value (0.28x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Tibet Cheezheng Tibetan Medicine Co Ltd's assets grew by 7.8% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Tibet Cheezheng Tibetan Medicine Co Ltd (2006–2024)

The table below shows the annual total assets of Tibet Cheezheng Tibetan Medicine Co Ltd from 2006 to 2024.

Year	Total Assets	Change
2024-12-31	CN¥6.79 Billion ≈ $993.65 Million	+7.81%
2023-12-31	CN¥6.30 Billion ≈ $921.67 Million	+7.00%
2022-12-31	CN¥5.89 Billion ≈ $861.40 Million	+5.73%
2021-12-31	CN¥5.57 Billion ≈ $814.74 Million	+24.86%
2020-12-31	CN¥4.46 Billion ≈ $652.51 Million	+49.43%
2019-12-31	CN¥2.98 Billion ≈ $436.67 Million	+29.03%
2018-12-31	CN¥2.31 Billion ≈ $338.43 Million	+0.71%
2017-12-31	CN¥2.30 Billion ≈ $336.06 Million	+10.64%
2016-12-31	CN¥2.08 Billion ≈ $303.74 Million	+0.27%
2015-12-31	CN¥2.07 Billion ≈ $302.93 Million	+15.53%
2014-12-31	CN¥1.79 Billion ≈ $262.21 Million	+16.77%
2013-12-31	CN¥1.53 Billion ≈ $224.55 Million	+7.12%
2012-12-31	CN¥1.43 Billion ≈ $209.63 Million	+5.53%
2011-12-31	CN¥1.36 Billion ≈ $198.65 Million	+2.84%
2010-12-31	CN¥1.32 Billion ≈ $193.16 Million	+1.75%
2009-12-31	CN¥1.30 Billion ≈ $189.84 Million	+105.50%
2008-12-31	CN¥631.30 Million ≈ $92.38 Million	+22.65%
2007-12-31	CN¥514.70 Million ≈ $75.32 Million	-12.91%
2006-12-31	CN¥590.98 Million ≈ $86.48 Million	--

About Tibet Cheezheng Tibetan Medicine Co Ltd

SHE:002287 China Biotechnology

Market Cap

$1.90 Billion

CN¥13.01 Billion CNY

Market Cap Rank

#6455 Global

#1459 in China

Share Price

CN¥22.74

Change (1 day)

-0.26%

52-Week Range

CN¥21.90 - CN¥35.78

All Time High

CN¥1299.72